To illustrate this point, in the context of colorectal cancer (CRC), the presence of cancer-associated fibroblasts that express the melanoma cell adhesion molecule (MCAM) has been shown to correlate with a more aggressive clinical course and a poorer prognosis for patients [31]. This evidence concerns the gene MCAM and colorectal carcinoma.